QA: Niagen Bioscience Inc in us_medicinal_products/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001386570_2021_Niagen_Bioscience_Inc.pdf

Logs

Graph

Absolute values for 0001386570, Niagen Bioscience Inc

  xvar xval
0 LiabilitiesNoncurrent 997,000
1 LiabilitiesCurrent 16,476,000
2 remainder_Liabilities 4,461,000
3 AssetsCurrent 32,219,000
4 AssetsNoncurrent 1,851,000
5 PropertyPlantAndEquipmentNet 3,206,000
6 Goodwill 1,082,000
7 remainder_Assets 0
8 GeneralAndAdministrativeExpense 75,379,000
9 ResearchAndDevelopmentExpense 3,732,000
10 remainder_Expenses 0
11 remainder_Revenues 59,257,000
12 remainder_NetIncome -71,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Liabilities 21,934,000
1 Assets 38,358,000
2 Expenses 79,111,000
3 Revenues 59,257,000
4 StockholdersEquity 16,424,000
5 NetIncome -19,925,000
6 ComprehensiveNetIncome -19,925,000
7 BaseVar 99,365,500
8 EconomicCapitalRatiobeforeLimitedLiability 0.0854
9 EconomicCapitalRatio 0.930

Edgar->Model Mapping

Feature Distribution

Change over Time